Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04238715 |
| Consolidated Lead Sponsor | Eisai |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 63 participants (ACTUAL) |
| Registered Start Date | 2020-01-22 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The First Affiliated Hospital of Bengbu Medical College | Bengbu, China | Open Hospital Dossier -> |
| Anhui Provincial Hospital | Hefei, China | Open Hospital Dossier -> |
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Xiamen University | Xiamen, China | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Eisai across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.